Diana Hull
University Hospitals Birmingham NHS Foundation Trust(GB)Cancer Research UK Clinical Trials Unit(GB)University of Birmingham(GB)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, Liver Disease Diagnosis and Treatment, Adipose Tissue and Metabolism, SARS-CoV-2 and COVID-19 Research, Hepatocellular Carcinoma Treatment and Prognosis
Most-Cited Works
- → Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study(2015)2,058 cited
- → Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis(2015)426 cited
- → The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers(2013)326 cited
- → Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial(2017)154 cited
- → Migration, adaptation, and illness: A review(1979)153 cited
- → Virus-Directed Enzyme Prodrug Therapy: Intratumoral Administration of a Replication-Deficient Adenovirus Encoding Nitroreductase to Patients With Resectable Liver Cancer